Schering Stiftung


Prof. Regev and a team member

Prof. Regev and a team member
Photo: Foundation for the National Institutes of Health

Aviv Regev: From Cell Atlases to Therapies in Cancer

Public Scientific Lecture

Prof. Regev and a team member
Photo: Foundation for the National Institutes of Health

Aviv Regev: From Cell Atlases to Therapies in Cancer

Public Scientific Lecture


September 08, 2021, 3–4:15 p.m.

The lecture is aimed at scientists and students.


LINK to Zoom-Meeting

Meeting ID: 935 6650 9572

Passcode: 551017

In cooperation with the Max Planck Institute for Molecular Genetics (MPIMG) the Schering Stiftung presents a public scientific lecture by this year’s Ernst Schering Prize laureate Professor Aviv Regev, PhD.

Tumors are complex cellular ecosystems, combining malignant and non-malignant cells through spatial, temporal and functional relations. Single-cell and spatial profiling has opened the way to create cell atlases of patient tumors and cancer models as roadmaps to understand how these ecosystems form and sustain tumors in patients, how they respond to therapies, and how resistance emerges. In this talk, Aviv Regev will show how she used these approaches to decipher cellular ecosystems in patient tumors, dissect the relation between genotype to phenotype in cancer, understand tumor progression and drug resistance, and identify new points for therapeutic interventions across the tumor ecosystem.

The lecture is aimed at a scientific audience.

Award Ceremony 2021 

Aviv Regev 

Award ceremony — September 07, 2021

Schering Stiftung awards Ernst Schering Prize to the computional biologist Aviv Regev. The physician and junior research group leader Judtih Feucht will be awarded with the Friedmund Neumann Prize.

Learn more
Prize winner

The bioinformatician Aviv Regev receives the Ernst Schering Prize 2021 for her research in the field of single-cell analysis and the innovative combination of biology and computer science.

Learn more


Aviv Regev is Executive Vice President and Global Head of Genentech Research and Early Development at the biotechnology company Genentech, a member of the Roche Group. Prior to Genentech, Regev served as founding director of the Klarman Cell Observatory at the Broad Institute, Professor of Biology at MIT, and Investigator of the Howard Hughes Medical Institute. She is a founding co-chair of the Human Cell Atlas. Aviv Regev has pioneered the development of foundational experimental and computational methods in single-cell genomics and is a leader in deciphering molecular circuits that govern cells, tissues, and organs in health and disease. Among many honors, she is an elected member of the National Academy of Sciences and the National Academy of Medicine in the United States.



This Project is realized in cooperation with the following partners:

Max Planck Institute for Molecular Genetics

You might also be interested in

September 07, 2021, Berlin

Ernst Schering Prize 2021 & Friedmund Neumann Prize 2021

Festive Award Ceremony in honor of Aviv Regev und Judith Feucht

September 07, 2021

Aviv Regev: Cell Atlases as Roadmaps in Health and Disease

Ernst Schering Prize Lecture 2021


Contact & social networks

Schering Stiftung

Unter den Linden 32-34
10117 Berlin

Telefon: +49.30.20 62 29 62

Opening hours
Project space

Thursday to Monday: 1 pm - 7 pm
Saturday to Sunday: 11 am - 7 pm
free entrance

Follow us!

Follow us on our social media channels to find out the latest developments!

facebook Youtube Instagram